The company is also working with the UK charity to call for the creation of international standards in the training and deployment of sniffer dogs.
Earlier this week, Medical Detection Dogs announced the findings of its research on scenting COVID-19, confirming that dogs can play a major role in public safety through their ability to detect the virus’ odour.
Researchers will now move to trial the dogs at sites such as ports of entry and public spaces, where dogs can screen individuals rather than samples and contribute to the fight against the virus by detecting COVID-19 carriers.
Sniffer dog schemes are currently being piloted in countries including Finland, Russia, Italy and France, but there is currently no centralised best practice process for such programmes.
Medical Detection Dogs and Purina are calling for:
Medical Detection Dogs founder and CEO Dr Claire Guest said: “Sniffer dogs have the potential to make an important contribution to the fight against COVID-19 and future pandemics. Researchers around the world are urgently working to meet that need, but it is vital that we collaborate, share the knowledge we have gained on the incredible abilities of our dogs and formalise best practice in training and deployment.
"Along with Purina we want to call for international collaboration between organisations around the world on the implementation of disease detection and research. Our vision is to guarantee that dogs are well-treated and consistent in their performance, and support the reliable, safe creation of similar schemes in developing countries, where dogs could play a huge role in halting the spread of this disease and future pandemics.”
Jeff Hamilton, CEO at Nestlé Purina PetCare EMENA, said: “Purina and Medical Detection Dogs share a belief in the positive role and impact of dogs in society. These dogs could provide fast, effective and non-invasive diagnosis and help to create safer spaces for us all, but we should ensure that each of them is trained safely, humanely and able to effectively perform their important role in detecting COVID-19."
According to the charity, one in ten homeless people have a pet, which is around 32,000 people in the UK. However, the majority of hostels do not accept animals, so they are unable to access accommodation.
The new StreetVet Accredited Hostel Scheme will make sure that hostels are well-equipped to support pet-owning residents. This includes having a variety of pet-friendly health, hygiene and safety policies; access to vet care including telemedicine, free provision of pet essentials, transport to vet practices when needed, emergency kennelling should the pet owner be taken ill and trained hostel team members able to offer support.
The scheme - which will roll out nationwide – has launched today with its first accredited site, The Elms in Hemel Hempstead.
The charity was able to launch the programme after winning £41,000 in funding from Purina’s BetterwithPets Prize which rewards social entrepreneurs and innovators seeking to harness the pet-human bond to tackle societal issues.
StreetVet co-founder Jade Statt MRCVS said: “Under current regulations, if people turn down housing due to 'no pets' clauses, they are told they are making themselves 'intentionally homeless' and are refused further housing assistance. Any pet lover will understand that choosing between a roof over your head and the company of your beloved pet is no choice at all.
"Our hope is that in setting up the StreetVet Accredited Hostel Scheme, fewer people will have to make this impossible choice. Access to pet-friendly hostels is their first step towards independent housing. With homelessness on the rise due to the economic impact of COVID-19, it was important to us to launch this scheme before Christmas, as winter sets in."
Bernard Meunier, Purina EMENA chief executive said: “This great achievement demonstrates how a programme built on deep love for pets and their owners, and belief in the power of the pet-human bond, can deliver positive change for both individuals and communities. And this is what we want to achieve with ourBetterwithPets Prize.”
For more information, visit https://www.streetvet.org.uk
Nutritional researcher Brian Zanghi from the Purina Institute will also share some of his work, which has focused on nutrient-enriched ‘water supplements’ and the impact on voluntary water intake.1
Purina says various studies have shown an association between increased water intake and improved outcomes in cases of feline lower urinary tract conditions.2,3 Encouraging water intake may also benefit cats with renal disease or chronic constipation, as well as older animals with osteoarthritis who might be less keen to make repeated trips to their water bowls.
Libby Sheridan, MVB, MRCVS, Purina Veterinary Technical Affairs Manager, UK & Ireland, said: "The importance of good hydration is often under estimated and there are so many factors that can influence intake – from the position of the water bowl, to materials used in the bowl construction and even the level of fill. Deciding when and how to promote increased intake can be difficult and we hope this session will help vets and vet nurses to make those decisions.”
The lecture programme will include a review of clinical evidence, discussion of the benefits of increasing water intake and practical case-based advice from Sarah and Andy. The event will be recorded for registrants who cannot attend on the day and registrations are accepted until the event starts on the evening of 9th December.
Registration is now open at https://www.bigmarker.com/closerstill-media/You-can-lead-a-cat-to-water-but-how-do-you-make-them-drink. All registrants will be entered into a prize draw to win one of ten goody bags which will include a premium water bottle.
For more information, contact the Purina Veterinary Nutrition Team on 0800 212161.
References
The successful candidates, who completed their studies during 2020 and passed the examination in November, are Lucy Wilson (pictured right), from Equibreed UK, Reading, Vanessa Austin, who works at at Vets4Pets, Northampton, and Donna Johnson, the Clinical Services Manager at The Pet Vet, Barnsley.
Lucy said: “I chose to do the CVPM to cement my knowledge of how to run our practice to the best of my ability and to provide the highest level of support to my colleagues. The CVPM resources, syllabus and experience have given me a thorough understanding of my skills and areas to develop. I cannot recommend the experience highly enough.”
Chair of the VMG Certification and Training Committee, Philippa Davies, said: “The CVPM exam tests candidates’ skills in operational management, prioritising, strategy, and thinking on your feet. It’s a gruelling assessment and holders are an elite group. We are delighted to welcome Vanessa, Donna and Lucy and congratulate them on their achievement.”
For more information, visit: https://www.vetmg.com/education/cvpm/
Drawing attention to the symptoms of allergic skin disease that owners should look out for during the warmer months, the leaflet, poster and notice board materials discuss some of the substances that dogs can be allergic to, how to manage skin allergies and what to look for in an itch prevention plan.
The materials have been produced to support Apoquel, the oral therapy for the treatment of canine pruritus associated with allergic dermatitis and the clinical manifestations of atopic dermatitis. They feature two dogs – Eric and Daisy – whose lives have been changed by the product.
For more information, contact your Zoetis account manager.
Lynda Maris, NexGard™ Spectra Product Manager said: "The campaign, which is designed to raise awareness of the rising threat from ticks, lungworm and other parasites that can endanger the health of pets and their owners, is reaching millions of pet owners."
A radio day, during which presenter Jenni Falconer and Merial vet Mike Woodhouse (pictured) discussed parasites and called on owners to visit their practice, apparently reached nearly 3 million listeners via 16 radio stations from BBC Radio Guernsey in the south, to Waves radio in Peterhead and Aberdeen.
The campaign has also been promoted with advertising on Newslink, which broadcasts to 287 stations including: Kiss, Capital, Star, Magic, Talk Sport, Classic and Absolute.
Participating practices have been send campaign support packs and Merial has provided educational and competition social media content to share on Facebook and Twitter. According to the company, its campaign Facebook page has reached reached over 1 million unique users in the last 28 days. Over the same period, Merial says 25,000 unique users have received campaign content on Twitter.
Practices can also direct clients to the campaign website www.petparasiteaction.co.uk.
Pet Parasite Action runs throughout June and July, so there's still time to get involved. For more information, contact your Merial Territory Manager, or call the company on 0870 6000 123.
Companion Care Vets has reported a record calendar year in 2010, with 15 new surgeries opened taking the network up to 69.
Companion Care also welcomed 17 new joint venture partners, increasing the total number of partners to 87. The company expects to double the number of surgeries over the next 3 years following the announcement that it is to open standalone practices alongside the in-store Pets at Home surgeries.
According to the company, the opening of 15 new full service surgeries represents an investment of approximately £3 million during the year. More than £340,000 of that investment went on state-of-the-art digital x-ray imaging equipment - a feature of all new surgeries.
Managing director, Jane Balmain, said: "The in-store model has been hugely successful and we will continue to accelerate our growth plans for in-store surgeries as the Pets at Home store footprint expands.
"The launch of our new standalone division provides a solution for the vets and nurses who are looking for a partnership but whose preference is for a more traditional standalone style surgery. The level of interest since our announcement has been massive and we will be looking to capitalise on this in 2011 and beyond.
"Our vision is for Companion Care Vets to become a truly national leading veterinary group and with the record year in 2010 and our plans for 2011 and beyond, we are now well on the way and confident of achieving this."
Dechra Veterinary Products has reduced the price of two key products in its Veterinary Essentials range to help practices respond to the challenging economic climate.
Atipam 5 ml is now the same price per ml as Atipam 10ml. Used for the reversal of the sedative effects of medetomidine and dexmedetomidine in cats and dogs, practices can now choose the size that suits them best. Additionally, during January, for every 15ml purchased an extra 5ml will be provided to practices free of charge.
Thyroxyl, used for the treatment of hypothyroidism in dogs, has also been reduced in price by 15 per cent. Practices that include Thryoxyl as part of the newly introduced Essential Purchase Plan can also make further savings.
To find out more about the Veterinary Essentials range, including further costs savings with an Essentials Purchase Plan and free margin development advice, call Liz Rawlings on 01743 441632.
This year, there have been over 30,000 nominations for the awards.
The finalists this year are:
Vet of the YearAndrew Hayes, Towcester Equine Vets, TowcesterClare McCabe (pictured right), Claymill Veterinary Clinic, CookstownLaurence Behrens, Goddard Veterinary Group, Dagenham
Vet Nurse of the YearCaroline Jones, Battle Flatts Veterinary Surgery, YorkHelen Rooney, Pet Blood Bank, LoughboroughLesley Ramsey, Debenham Veterinary Practice, Stowmarket
Practice Support Staff of the YearRhiannon Lewis, Streatham Hill Vets, StreathamLaura Cameron, Lomond Veterinary Clinic, HelensburghLouise O’ Reilly, Vets4Pets, Llanrumney
Practice Manager of the YearKristen Lorimer, Blue House Veterinary Centre, Stoke-on-TrentLouise Newman, Blue Cross Vets, MertonNicki Ridgeway, Vets4Pets, Ridgeway
Practice of the YearHollybank Veterinary Centre, NorthwichLanes Vets, PoultonMilfeddygon Williams Vets, Gwynedd
The awards will be hosted at the Kimpton Clocktower Hotel, Manchester on 23rd March.
Bella von Mesterhazey, Sales & Marketing Director at Petplan, said: “This year’s finalist line-up includes an outstanding array of veterinary professionals and practices, and Petplan is delighted to be celebrating the highest achievements in pet healthcare once again."
The researchers’ objective was to determine whether dogs with intracranial space occupying lesions (iSOLs) on MRI, or MRI-determined indicators of intracranial hypertension (ICH) had higher sedation scores with a more rapid onset of recumbency after the administration of IV butorphanol than dogs without intracranial disease.
They hypothesised that 0.2 mg kg-1 of butorphanol administered intravenously would result in statistically significantly higher sedation scores and quicker onset of recumbency in dogs with MRI-iSOL and MRI-ICH.
For the observational study: 'The sedative effect of intravenous butorphanol in dogs with intracranial space occupying lesions or indicators of intracranial hypertension', 53 dogs presented for a brain MRI.
Each dog was sedated with 0.2 mg kg-1butorphanol IV, and the quality of sedation and the onset of recumbency were scored before drug administration and every 5 minutes after administration for 15 minutes using a modified sedation scale.
The maximum sedation score was 18, and onset of recumbency was recorded when a dog lay down without the ability to stand.
Dogs with MRI-iSOL had significantly higher median sedation scores than dogs without MRI-iSOL (12 versus 5 respectively) 15 minutes after butorphanol administration (T15, p < 0.01).
A greater number of dogs with MRI-ICH achieved recumbency (n = 9/10; 90%) than those without MRI-ICH (n = 20/43; 46.5%; p = 0.01).
Emma Sansby, Resident in Anaesthesia and Analgesia at Lumbry Park Veterinary Specialists, who led the research, said: “When intracranial disease is suspected, the administration of butorphanol as a premedicant for anaesthesia could be used to predict the presence of MRI-iSOL and MRI-ICH.
"If a dog becomes recumbent or has a sedation score of more than 10 within 15 minutes of butorphanol administration, the animal should be treated with an anaesthesia protocol adapted to the presence of ICH – so as not to increase intracranial pressure.
“These adaptations include but are not limited to; adequate preoxygenation - to prevent hypoxaemia and elevation of the head to no more than 30 degrees; preventing increases in central venous pressure - by avoiding jugular compression and avoiding excessive intraabdominal and intrathoracic pressure; and a smooth anaesthetic induction - ensuring an adequate depth of anaesthesia prior to tracheal intubation to prevent the cough reflex and judicious mechanical ventilation to enable a low-normal end-tidal carbon dioxide.”
Reference
Photo: www.depositphotos.com
A donation of 200 Tracer microchips by Bayer is helping to save one of the world's largest and rarest species of frog against extinction. A deadly fungal disease, responsible for decimating global amphibian populations, is threatening the last known wild population of the 'mountain chicken' frog (Leptodactylus fallax).
The eastern Caribbean island of Montserrat is the last global stronghold for this species - known locally as mountain chicken due to its taste. As recently as 2002, chytridomycosis wiped out the majority of mountain chicken frogs on the island of Dominica. Recent tests on dead frogs found in the west of Montserrat have confirmed the presence of this disease.
The Durrell Wildlife Conservation Trust has been working in Montserrat since the early 1990s to support the local government in the protection of the island's vast biodiversity. The mountain chicken has been an important species, and Durrell holds the largest safety net population at its Jersey headquarters.
In response to the positive identification of the disease, Durrell has launched an emergency plan to rescue healthy frogs and put in place longer treatment and management plans for the protection of the species.
Bayer's donation of 200 Tracer microchips will be used to individually identify the captive mountain chickens held by Durrell to help manage a breeding programme. Durrell is also testing the feasibility of treating the frogs with antifungals in their natural habitat, and the use of the donation of microchips will be essential to allow individual frogs to be monitored to assess the outcomes of treatment regimes.
Durrell's head of veterinary services, Javier López, has worked with mountain chickens for a number of years, and explains that the disease could very quickly wipe out the species. Captive populations of healthy frogs, such as the one in Jersey, could be used to initiate re-introductions back to the wild or in disease-free areas.
Complete Veterinary Care (CVC) is to launch the BooBooLoon, a new alternative to the Elizabethan collar at BSAVA Congress.
According to the company, the inflatable collar offers comfort and protection advantages over old style Elizabethan collars and other devices that restrict pets from harming surgical wounds and irritating skin disorders.
The BooBooLoon, which is made in the US by a manufacturer called Headroom, will be distributed by CVC to veterinary professionals and pet shops. The collar will be available in five sizes from extra small through to extra large.
Marcy Colangelo, President of Headroom invented the device when her boxer dog Mitzi had surgery for skin cancer. She said: "I just couldn't stand leaving that cone on her. It was like putting her head in a tunnel."
Inspired by her own travel pillow, she came up with the BooBooLoon.
Marcy added: "I know the entire CVC Group administrative and veterinarian management team are enthusiastic about their upcoming BooBooLoon inflatable pet recovery collar launch. The CVC Group is very experienced and is committed to providing excellent service and quality to the veterinary profession and to independent pet shops throughout the United Kingdom."
Companion Care Vets has announced that it will open its 100th surgery in Llantrisant, South Wales on 7th September 2012.
The surgery will reside within the Pets at Home store in Llantrisant and will be owned and managed by Joint Venture Partner Rhian Bullock who has returned home to Llantristant after working and studying for many years in the USA.
Jane Balmain, Managing Director, Companion Care Vets said: "2012 has been quite a year for the business, we were named as one of The Sunday Times 100 Best Companies to Work For, becoming the first veterinary group to be awarded this accolade. Our growth has been such that we have recently launched a dedicated recruitment website, we have employed our 1,000th team member and to be opening our 100th surgery is testament to the hard work and dedication of our fantastic team."
Companion Care now has 117 Joint Veterinary Partners, 96 of whom are veterinary surgeons, 13 veterinary nurses, 7 practice managers and a receptionist and a further 953 colleagues employed by the group. The company says it has doubled in size in the past three years and is on track to do so again by 2015.
Jane said: "At present the majority of our surgeries are part of the Pets at Home in-store model but there are already five very successful standalone surgeries and the standalone surgery network plan is being developed to cater for those vets and veterinary nurses whose preference is to have a more traditional standalone surgery."
Rhian said: "A local girl, I have just moved back to Llantrisant and am really excited to be running my own practice in an area that I love. I set myself very high clinical standards and always involve the client in treatment and their pet's wellbeing. There is nothing that satisfies me more than well animals and happy clients."
Rhian and her team are involving the local community in the opening and will have guests from local branches of the Dogs Trust and the Cats Protection League present on opening day raising funds and joining in the celebrations.
Virbac has launched Inflacam, a meloxicam-based NSAID for the alleviation of pain in both acute and chronic musculo-skeletal disorders in dogs and horses.
Inflacam is presented both as an oral suspension and as a chewable tablet for dogs. The suspension is available in 200ml, 100ml, 42ml and 15ml sizes with a measuring syringe provided. The tablets come in two sizes - 1 mg and 2.5 mg - and are available in packs of 100. It is available for horses as an oral suspension.
Virbac Product Manager Chris Geddes MRCVS, said: "Virbac is well known for launching innovative products in areas such as dermatology and reproduction but we also aim to support practices by offering tried and trusted practice 'standards' for everyday use. Inflacam fits this brief well - meloxicam is the most commonly-used NSAID in dogs and we are delighted to add it to our range."
For more information contact your territory manager or call Virbac on 01359 243 243.
The Royal College of Veterinary Surgeons has set up a new Veterinary Legislation Group to consider proposals for changes in veterinary regulation, in the light of the Environment, Food and Rural Affairs Committee's inquiry into the current Veterinary Surgeons Act, and the Government's response to the EFRA Committee's report.
The new group, which will be chaired by RCVS Council Member and Dean of Glasgow Veterinary School, Professor Stuart Reid, will be tasked with taking a fresh look at changes that need to be made to the current legislative framework, and how these might be accomplished. It will not restrict itself to looking at a replacement for the Veterinary Surgeons Act, but will consider other ways that changes can be made in the short- and long-term.
The Group will meet in September, and comprise RCVS Council members and non-members - both lay people and veterinary surgeons. Once the RCVS position has been clarified, further discussion will follow with DEFRA, the BVA and the profession.
Responding to the Government's response to the EFRA Committee report, RCVS President Jill Nute said: "We welcome the fact that DEFRA is willing to consider any detailed proposals that might come forward from the profession, although we accept that DEFRA itself does not have time or resources to be proactive at this stage.
"We are also pleased that Government acknowledges that the veterinary nursing profession has come of age and that the time is right for the regulation of veterinary nurses to be taken forward, although again it is disappointing that DEFRA does not have the resources to progress this at present.
"Finally, we welcome the suggestion that the Presidents of the BVA and the RCVS meet with the Chief Veterinary Officer to discuss plans and to what extent DEFRA can help us - accepting the fact that DEFRA, like the RCVS, feels that a piecemeal approach may not be the most effective," she concluded.
Genitrix has repackaged its Dentagen plaque prevention chews to provide added value and convenience to pet owners.
Packs of the chews, launched in 2008 as part of Genitrix' Dentagen dental range, will now be available in 'one month' packs in response to customer feedback. The new, bigger value packs will also be priced more cost-effectively and will offer environmental benefits as the amount of packaging is reduced.
Dentagen dental chews are impregnated with a plant extract called RF2 which enables them to act as an 'anti-biofilm' treatment, modifying the membrane of oral bacteria to prevent them from producing plaque. The chews, which come in two sizes for large and small dogs, are designed to be given on alternate days and form part of the unique Dentagen Dental Care Programme. Earlier this year, Genitrix also launched Dentagen Aqua, an innovative water additive treatment to control plaque and prevent bad breath in cats and dogs.
The new size packs of Dentagen chews, which will be available exclusively through veterinary channels, cost £6.35 for a pack of 14 small chews (one month's supply) and £8.09 for 14 large chews.
The webinar will take place at 11am and will be repeated at 7.30pm for those who are unable to listen during the day.
Hosted by Zoetis vet Dr Wendy Talbot the session will last for approximately an hour and equates to 8 AMTRA CPD points.
Wendy will explain the current situation and recommended approaches to help slow resistance.
The webinar will conclude with a live Q&A to give everyone the opportunity to discuss any queries, concerns or common questions they hear from their customers with Wendy.
Zoetis Equine Product Manager, Penny McCann said: "Our webinars continue to be very well received.
“This one is particularly important as it explains the important new thinking around the use of anthelmintics in order to address the serious challenge of resistance.
"It’s a must for all those involved with prescribing.”
To book the 11am webinar: https://register.gotowebinar.com/register/6163460189961597967 To book the 7.30pm webinar: https://register.gotowebinar.com/register/6394015684169009164
On Thursday 16th June at 4:00pm, Dr Jude Capper, PhD DSc (h.c.) ARAgS, livestock sustainability consultant and ABP chair in sustainable beef production at Harper Adams University, will present 'Managing Fertility to Enhance Sustainability'.
On Thursday 21st June at 4:00pm, Dr Stephen Butler, MAgrSc MSc PhD, principal research scientist and group leader for dairy cattle reproduction research at Teagasc, Ireland’s Agriculture and Food Development Authority (pictured right), will present 'Using Sexed Semen in Dairy Herds', followed by Dr Tom Clark, BVSc MRCVS, veterinary surgeon and clinical director of Synergy Farm Health, who will present 'Practical Implementation of Sexed Semen Strategies'.
The webinars will update vets on how they can support the improvement of reproductive sustainability on dairy farms and provide new data demonstrating how they can promote the implementation of sexed semen protocols in dairy herds.
They will also include information on the practical use of sexed semen strategies with useful hints and tips from on-farm case studies and scenarios.
To register, e-mail cevauk-webinars@ceva.com giving your name, practice name and the date(s) of the event you wish to attend.
Further details and the link will be sent out before the webinar.
Cranial cruciate ligament insufficiency (CCLI) affects 3% to 5% of dogs1.
Past research has demonstrated satisfactory short (6-12 weeks)2 and medium (mean 16 months)3 term outcomes for lame dogs treated with TTA.
However, Steve says there is limited research on longer (>16 months) follow-up periods.
It has also been speculated that dogs with tibial plateau angles (TPA) of greater than 30⁰ are not well suited for a TTA4.
For the study5, the researchers reviewed patient records for a total of 149 TTA-Rapid procedures carried out in 120 dogs over an 80 month period.
They also reviewed owner questionnaires that evaluated the outcome of at least six months after surgery, using a validated clinical metrology instrument, Liverpool Osteoarthritis in Dogs (LOAD).
Follow-up questionnaires were received from owners of 64 of the 120 dogs (53.3%), with a median follow-up time of 37.5 months.
This cohort included a wide range of breeds, aged between 2&12 years and with bodyweights ranging from 6.3 to 41.8kg.
The dogs included 37 females and 27 males, and of the 79 limbs treated in these dogs, 41 were left and 38 were right.
The researchers found 26 of the dogs (40.6%) had a TTA performed with a TPA less than 30◦ and 38 (59.4%) with a TPA of 30◦ or more.
Of the 79 procedures, meniscal injury was noted in 27 (34.2%), surgery to stabilise the patella was required in 11 (13.9%), there was one surgical site infection (treated successfully with a short course of antibiotics), one dog sustained a fracture of the tibial seven days after surgery, and one sustained a late meniscal tear 12 months after initial surgery (treated successfully by partial meniscectomy).
The outcome was judged to be satisfactory, based on frequency of lameness, in 63 (98.4%), while satisfactory outcomes were achieved in 61 (95.3%) based on severity of lameness and in 50 (78.1%) based on mobility score.
Statistical analysis showed that age, bodyweight, tibial plateau angle (TPA), meniscal injury, and concurrent patellar surgery did not influence the outcome, but time to follow-up positively correlated with mobility score (suggesting mobility declined with time from surgery).
The researchers concluded that the long-term (median of 37.5 months) outcome for dogs undergoing TTA-Rapid for cranial cruciate ligament disease is satisfactory, with no risk factors associated with poorer outcomes identified.
The study also revealed no evidence to support the suggestion that dogs with TPAs of greater than 30◦ may be inappropriate candidates for TTA - after testing several parameters to judge outcome including frequency of lameness, severity of lameness, distance walked daily and mobility score.
Steve said: “This research is important in trying to ensure that decisions on whether to use this treatment modality, are based on sound clinical evidence.
"The only factor identified that influenced the outcome measure was that of time since surgery.
"All other factors, including TPA, had no effect on the outcome.”
ESCCAP says that the risk of novel parasites and zoonoses spreading to new regions has risen alongside an increase in pet travel and changing climate conditions.
ESCCAP’s Guideline 09 offers detailed advice on how to protect dogs and cats that travel or are imported across European borders, minimise the risk of zoonotic transmission and prevent the establishment of new parasites in previously unaffected areas.
Topics covered in the guideline include:
The guideline emphasises the importance of early detection of parasitic infections by thorough clinical examinations, comprehensive travel history assessments and targeted diagnostic testing.
It also provides guidance on educating pet owners about zoonotic risks and implementing appropriate treatments and follow-up screenings.
www.esccap.org/guidelines/gl9/
A survey carried out by CEVA Animal Health, manufacturer of the pheromonatherapy products D.A.P.® and Feliway®, has revealed that 94 per cent of veterinary professionals believe that owners' lifestyles are the major cause of behavioural problems in pets1.
Over three-quarters of those questioned believed that owners should spend more time with their pets to prevent these issues, while 89 per cent thought that owners were too busy to deal with their pets if they developed behavioural problems.
According to CEVA, the fast pace of owners' lifestyles is significantly affecting the stress felt by both dogs and cats and this is further exacerbated in cats by the social demands that pet owners put on them. Cats are solitary survivors that cope better with short, frequent interactions and like their own company. While they are popular for their independence, owners often like to have their pets' full attention when they return from work which is at odds with their cats' preferred behaviour patterns.
Behavioural issues can also result from changes in a pet's environment and new experiences such as moving house, building work, the introduction of a new pet to the household, going to a kennel or cattery, travelling in a car, visiting the vets and stressful events such as Bonfire Night and Christmas. To help combat stress, nearly 65 per cent of dog owners avoid putting their pets in stressful situations, while 19 per cent choose to ignore their stressed dog2.
Lucy Brett, product manager at CEVA Animal Health said: "Our modern lifestyles are leading to stressed pets which, in the long-term, will exacerbate behavioural and medical problems. It's important that veterinary professionals educate their clients on the implications of canine and feline stress to help prevent these issues from developing."
For further information about D.A.P.® and Feliway®, please contact your CEVA Animal Health representative or call CEVA Animal Health on 01494 781510.
Vetericyn VF, the vet-only wound and skin care spray from Innovacyn has been named product of the year by Animal Health International, one of the world's largest food and companion animal health distributors.
Commenting on the award, Innovacyn said: "for an organisation the size and reputation of Animal Health International to give this top honour to Vetericyn is a great vindication of the product's efficacy but also the very positive feedback they have received from professional users."
Vetericyn VF is available throughout the UK from all the leading veterinary wholesalers. Further technical resources are available at: www.vetericyn.com/veterinarians or email enquiries to uk@vetericyn.com
Elanco Animal Health has announced the launch of a Milbemax television advertising campaign to educate pet owners about the importance and ease of worming.
The 30-second advertisement will appear as pre-roll to video content on a number of websites from the end of August, and will broadcast on mainstream TV channels including ITV1, Channel 4, Channel Five, Sky, ITV2, ITV3, E4, More4, Film4, UKTV and Five Digital in mid-September to reach an estimated nine million people – of which nearly three million will be identified/targeted pet owners.
Elanco says the advert is designed to target female pet owners between the ages of 25 and 49 and drive them to seek further information and buy pet wormers from their local veterinary surgeon with the call to action: ‘Make an appointment with your vet to find out how easy worming your pet can be.’
Viewers watching the online advertisement will be able to click through to campaign specific pages on Elanco’s WormPatrol website - www.wormpatrol.co.uk/easyworming - where they can use 'Find a Vet', a worm risk checker and worming reminders to connect them with veterinary practices. The advertisement will also be available to view on the WormPatrol website.
The campaign is supported by a range of educational marketing materials and initiatives which are available to Milbemax customers from the vet section of the WormPatrol website or from their local Elanco companion animal territory manager.
The materials include a video to embed in practice websites and to use on social media, a subtitled version of the video for waiting rooms, a range of pet owner worm education materials, social media resources and SMS text message broadcasts.
Matthew Rowe, marketing manager at Elanco Animal Health, said: “Elanco is committed to encouraging responsible pet ownership; the new Milbemax advertising campaign will educate pet owners about the importance and ease of regular worming while driving them to veterinary practices for further information and to purchase pet wormers.”
For further information please contact your local Elanco Animal Health territory manager or email elancoCAH.uk@elanco.com.
According to the company, the new Avacta Allergy+ offers:
Existing customers will be getting a launch pack this week, which comes with a box of Yorkshire teabags (as that's where Avacta heralds from) and a pack of chocolate biscuits so practice staff can take break whilst they peruse details of the new portfolio and accompanying support materials.
To encourage the reuse of the old Avacta submission boxes, the company is also running a competition where practices can win a £100 Amazon gift voucher if they come up with the most practical and imaginative reuse idea. Full details can be found at avactaanimalhealth.com/news.
For more information visit www.avactaanimalhealth.com.
Founder Professor Noel Fitzpatrick said: "It is a real joy to see the VET Festival growing and growing, not just in physical size, but from the immense goodwill that radiates from it. The weather didn’t get in the way of the wellness and there was nothing rainy about the atmosphere at VET Festival - in fact I think that the rain brought us closer together.
"I set out to build a community of compassion for our profession and I genuinely felt that there was a tangible sense of togetherness. There were loads of great conversations with each other and with the exhibitors. The educational content really was world class and the tents were packed. I hoped that VET Festival would be a breath of fresh air, where having an education event outdoors - combined with a focus on wellness of body and mind for all of us - could help vet professionals to be the very best that they could be - and so serve our patients better.
"Everyone there was part of something innovative and refreshing I felt – the delegates, the exhibitors, the team who have worked year-round to create the event, and the fantastic speakers. I’m very grateful to all of them and I sincerely hope that this feeling remains strong for each and every one all year round.
"The resonant theme this year was ‘kindness’ – to ourselves, to each other, to the families of animals and the animals we are lucky enough to take care of. Nobody is a nobody at VET Festival, and never will be. In that field, we’re all equal, no matter what we do in the vet profession - we all matter - we all want the same thing, which is wellness for each other and the animals we serve - and importantly, we’re all in it together for the greater good, rain or shine."